Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2021: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2020: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Outline of Final Research Achievements |
Vestibular schwannoma (VS) is the most common tumor of the cerebellopontine angle. The number of sporadic VS cases has increased rapidly over the last decade. Here, we completed a comprehensive genomic analysis of all the exons in the key tumor suppressor and oncogenes from small (< 15mm) sporadic VS samples. These evaluations identified NF2, SYNE1, IRS2, APC, CIC, SDHC, BRAF, NUMA1, EXT2, HRAS, BCL11B, MAGI1, RNF123, NLRP1, ASXL1, ADAMTS20, TAF1L, XPC, DDB2, and ETS1 as mutated genes and novel missense mutations in the SYNE1 transcript were identified in 20% of the samples.
|